Search Results

Filter
  • 1-10 of  145 results for ""Cholesterol Ester Transfer Proteins""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Evaluating obicetrapib as an emerging treatment for patients with dyslipidemia: a game changer?

  • Authors : Nicholls SJ; Victorian Heart Institute, Monash University, Melbourne, Australia.; Tan S

Subjects: Cholesterol Ester Transfer Proteins*/Cholesterol Ester Transfer Proteins*/Cholesterol Ester Transfer Proteins*/antagonists & inhibitors ; Dyslipidemias*/Dyslipidemias*/Dyslipidemias*/drug therapy ; Dyslipidemias*/Dyslipidemias*/Dyslipidemias*/blood

  • Source: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2024 Oct; Vol. 25 (14), pp. 1879-1885. Date of Electronic Publication: 2024 Sep 27.Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Guiding Dyslipidemia Treatment: A Population Pharmacokinetic-Pharmacodynamic Framework for Obicetrapib.

  • Authors : Dunn A; Center for Translational Medicine, School of Pharmacy, University of Maryland, Baltimore, MD, USA.; Ditmarsch M

Subjects: Dyslipidemias*/Dyslipidemias*/Dyslipidemias*/drug therapy ; Models, Biological* ; Cholesterol Ester Transfer Proteins*/Cholesterol Ester Transfer Proteins*/Cholesterol Ester Transfer Proteins*/antagonists & inhibitors

  • Source: Journal of clinical pharmacology [J Clin Pharmacol] 2024 Sep; Vol. 64 (9), pp. 1150-1164. Date of Electronic Publication: 2024 May 08.Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604

Record details

×
Academic Journal

CETP genotype and concentrations of HDL and lipoprotein subclasses in African-American men.

  • Authors : Samedy LA; Department of Pharmacy Practice, Mercer University, College of Pharmacy, 3001 Mercer University Drive, Atlanta, GA 30341, USA.; Ryan GJ

Subjects: Black or African American* ; Polymorphism, Genetic*; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*genetics

  • Source: Future cardiology [Future Cardiol] 2019 May; Vol. 15 (3), pp. 187-195. Date of Electronic Publication: 2019 May 31.Publisher: Future Medicine Country of Publication: England NLM ID: 101239345 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: A systematic review and meta-analysis.

  • Authors : Riaz H; 1 Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.; Khan SU

Subjects: Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*prevention & control ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*antagonists & inhibitors ; Cholesterol, HDL/Cholesterol, HDL/Cholesterol, HDL/*blood

  • Source: European journal of preventive cardiology [Eur J Prev Cardiol] 2019 Mar; Vol. 26 (5), pp. 533-543. Date of Electronic Publication: 2018 Dec 06.Publisher: Oxford University Press Country of Publication: England NLM ID: 101564430 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Lipopolysaccharide Lowers Cholesteryl Ester Transfer Protein by Activating F4/80 + Clec4f + Vsig4 + Ly6C - Kupffer Cell Subsets.

  • Authors : van der Tuin SJL; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Subjects: Antigens, Ly/Antigens, Ly/Antigens, Ly/*metabolism ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*metabolism ; Dyslipidemias/Dyslipidemias/Dyslipidemias/*metabolism

  • Source: Journal of the American Heart Association [J Am Heart Assoc] 2018 Mar 10; Vol. 7 (6). Date of Electronic Publication: 2018 Mar 10.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Electronic Cited Medium: Internet ISSN: 2047-9980

Record details

×
Academic Journal

HDL and Reverse Cholesterol Transport Biomarkers.

  • Authors : Riggs KA; THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, DALLAS, TEXAS.; Rohatgi A

Subjects: Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*therapeutic use ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*prevention & control ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*antagonists & inhibitors

  • Source: Methodist DeBakey cardiovascular journal [Methodist Debakey Cardiovasc J] 2019 Jan-Mar; Vol. 15 (1), pp. 39-46.Publisher: Methodist DeBakey Heart & Vascular Center Country of Publication: United States NLM ID: 101508600 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

CETP-Inhibition and HDL-Cholesterol: A Story of CV Risk or CV Benefit, or Both.

  • Authors : Nicholls SJ; South Australian Health and Medical Research Institute, University of Adelaide, Australia.

Subjects: Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*prevention & control ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*antagonists & inhibitors ; Cholesterol, HDL/Cholesterol, HDL/Cholesterol, HDL/*blood

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2018 Aug; Vol. 104 (2), pp. 297-300. Date of Electronic Publication: 2018 Jun 27.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535

Record details

×
Academic Journal

Success, Failure, and Transparency in Biomarker-Based Drug Development: A Case Study of Cholesteryl Ester Transfer Protein Inhibitors.

  • Authors : Hey SP; From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (S.P.H., J.M.F., J.A., A.S.K.); and Harvard Center for Bioethics, Harvard Medical School, Boston, MA (S.P.H., A.S.K.).

Subjects: Drug Approval* ; Endpoint Determination*; Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*therapeutic use

  • Source: Circulation. Cardiovascular quality and outcomes [Circ Cardiovasc Qual Outcomes] 2017 Jun; Vol. 10 (6).Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101489148 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increase.

  • Authors : Simic B; Center for Molecular Cardiology, Campus Schlieren, University of Zürich, Switzerland; University Heart Center, Cardiology, University Hospital Zürich, Switzerland. Electronic address: .

Subjects: Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*pharmacology ; Benzodiazepines/Benzodiazepines/Benzodiazepines/*pharmacology ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*antagonists & inhibitors

  • Source: Atherosclerosis [Atherosclerosis] 2017 Feb; Vol. 257, pp. 186-194. Date of Electronic Publication: 2017 Jan 16.Publisher: Elsevier Country of Publication: Ireland NLM ID: 0242543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1484

Record details

×
Academic Journal

Dyslipidaemia: Revealing the effect of CETP inhibition in cardiovascular disease.

  • Authors : Holmes MV; Medical Research Council Population Health Research Unit, University of Oxford; the Clinical Trial Service Unit &Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Roosevelt Drive, Oxford OX3 7LF, UK

Subjects: Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*pharmacology ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*prevention & control ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*antagonists & inhibitors

  • Source: Nature reviews. Cardiology [Nat Rev Cardiol] 2017 Nov; Vol. 14 (11), pp. 635-636. Date of Electronic Publication: 2017 Oct 05.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500075 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  145 results for ""Cholesterol Ester Transfer Proteins""